“Off-the-Shelf” Allogeneic CAR & TCR Cell Therapies for Virus-Associated Diseases

Time: 2:30 pm
day: Focus Day - Track A - Evening


  • Lack of T-cell immune control often leads to viral complications
  • Immune reconstitution through adoptive T-cell therapy can be safely used for preventing or treatment of virus-associated diseases
  • Off-the-shelf allogenic T-cell therapies offer rapid and effective therapeutic potential for virus-associated complications